-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Arbutus Biopharma Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
- Arbutus Biopharma Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.72M, a 18.5% increase year-over-year.
- Arbutus Biopharma Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $6.43M, a 44.6% increase year-over-year.
- Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2023 was $5.25M, a 1083% increase from 2022.
- Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2022 was $444K.
- Arbutus Biopharma Corp annual Nonoperating Income (Expense) for 2021 was -$2.73M, a 54.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)